Oluwatosin Efuntola Folorunso, MD
Pediatrics · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Folorunso’s office at (650) 934-7956 to ask if they take your plan before you enroll.
California Medical Board record
Licence A137163 · Current
Licensed to practise in California · since 2015 · expires 2027-02-28 · St. George'S University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$251,702 in 2023
Medicaid paid $251,702 for 8,571 billed services this clinician did in 2023, up to 249 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,830 | $250,105 |
| Screening performed and negative | 533 | $957 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 223 | $240 |
| Short return visit (20+ min) | 1,724 | $208 |
| Short return visit | 416 | $65 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 292 | $53 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 351 | $37 |
| Screening test, pure tone, air only | 476 | $11 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 234 | $9 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 112 | $9 |
| HEMOGLOBIN | 870 | $4 |
| Bilateral quantitative screening test of visual acuity | 519 | $4 |
| 2023 | 8,571 | 23 | 249 | $251,702 |
| 2022 | 7,824 | 28 | 263 | $188,977 |
| 2021 | 13,703 | 28 | 250 | $423,134 |
| 2020 | 7,980 | 22 | 252 | $248,420 |
| 2019 | 8,464 | 22 | 253 | $395,944 |
| 2018 | 7,335 | 20 | 323 | $467,434 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 1,399 | $188,554 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 224 | $240 |
| Screening performed and negative | 503 | $87 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 72 | $51 |
| Short return visit (20+ min) | 1,200 | $26 |
| Short return visit | 718 | $10 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 33 | $9 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 187 | $0 |
| Measurement of lead | 82 | $0 |
| HEMOGLOBIN | 776 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 76 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 145 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 3,150 | $422,949 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 58 | $55 |
| Short return visit (20+ min) | 2,359 | $46 |
| Screening test, pure tone, air only | 658 | $31 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 50 | $18 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 394 | $17 |
| Short return visit | 1,333 | $10 |
| HEMOGLOBIN | 1,229 | $6 |
| Bilateral quantitative screening test of visual acuity | 633 | $3 |
| Measurement of lead | 13 | $0 |
| Measurement of bilirubin | 23 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 109 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,862 | $248,358 |
| Short return visit | 760 | $40 |
| Screening performed and negative | 286 | $22 |
| Measurement of lead | 55 | $0 |
| HEMOGLOBIN | 731 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 96 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 65 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 177 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 225 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 129 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 128 | $0 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 109 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 3,009 | $395,944 |
| Measurement of lead | 87 | $0 |
| HEMOGLOBIN | 746 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 46 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 28 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 50 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 90 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 232 | $0 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 39 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 16 | $0 |
| Screening test, pure tone, air only | 338 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 3,523 | $466,512 |
| Short return visit (20+ min) | 1,531 | $486 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 57 | $137 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 258 | $111 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 107 | $63 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 34 | $36 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 33 | $18 |
| Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 13 | $18 |
| Varicella virus vaccine (VAR), live, for subcutaneous use | 14 | $18 |
| HEMOGLOBIN | 586 | $14 |
| Screening test, pure tone, air only | 206 | $11 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 40 | $9 |
Professional record
- NPI
- 1184976292
- Licence
- CA 137163California A137163: Current · expires 2027-02-28
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2012-10-12
- NPI last updated
- 2023-11-07
- NPI record certified
- 2023-11-07
This is when the NPI record was last certified, not a medical board exam.